Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gottfried Hirnschall, MD"'
Autor:
David Tordrup, MSc, Yvan Hutin, MD, Karin Stenberg, MSc, Jeremy A Lauer, PhD, David W Hutton, PhD, Mehlika Toy, PhD, Nick Scott, PhD, Marc Bulterys, MD, Andrew Ball, MD, Gottfried Hirnschall, MD
Publikováno v:
The Lancet Global Health, Vol 7, Iss 9, Pp e1180-e1188 (2019)
Summary: Background: The World Health Assembly calls for elimination of viral hepatitis as a public health threat by 2030 (ie, −90% incidence and −65% mortality). However, WHO's 2017 cost projections to achieve health-related Sustainable Developm
Externí odkaz:
https://doaj.org/article/6115b3e638fc474d8334fdc9fcec8471
Autor:
Jeffrey W Eaton, PhD, Nicolas A Menzies, MPH, John Stover, MA, Valentina Cambiano, MS, Leonid Chindelevitch, PhD, Anne Cori, PhD, Jan A C Hontelez, PhD, Salal Humair, PhD, Cliff C Kerr, PhD, Daniel J Klein, PhD, Sharmistha Mishra, MD, Kate M Mitchell, PhD, Brooke E Nichols, MS, Prof. Peter Vickerman, DPhil, Roel Bakker, PhD, Till Bärnighausen, DSc, Anna Bershteyn, PhD, Prof. David E Bloom, PhD, Marie-Claude Boily, PhD, Stewart T Chang, PhD, Ted Cohen, DPH, Peter J Dodd, PhD, Prof. Christophe Fraser, PhD, Chaitra Gopalappa, PhD, Prof. Jens Lundgren, DMSc, Natasha K Martin, DPhil, Evelinn Mikkelsen, MSc, Elisa Mountain, MSc, Quang D Pham, MD, Michael Pickles, PhD, Prof. Andrew Phillips, PhD, Lucy Platt, PhD, Carel Pretorius, PhD, Holly J Prudden, MSc, Prof. Joshua A Salomon, PhD, David A M C van de Vijver, PhD, Sake J de Vlas, PhD, Bradley G Wagner, PhD, Richard G White, PhD, David P Wilson, PhD, Lei Zhang, PhD, John Blandford, PhD, Gesine Meyer-Rath, PhD, Michelle Remme, MSc, Paul Revill, PhD, Nalinee Sangrujee, PhD, Fern Terris-Prestholt, PhD, Meg Doherty, PhD, Nathan Shaffer, MD, Prof. Philippa J Easterbrook, MD, Gottfried Hirnschall, MD, Prof. Timothy B Hallett, PhD
Publikováno v:
The Lancet Global Health, Vol 2, Iss 1, Pp e23-e34 (2014)
Background: New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive adults with CD4 counts of 500 cells per μL or less, a higher threshold than was previously recommended. Country decision makers have to decide whether to
Externí odkaz:
https://doaj.org/article/9bd6c2f8c1b9479a8165b343ebb7c4e9
Autor:
Daniel Keebler, SM, Paul Revill, MSc, Scott Braithwaite, MD, Prof. Andrew Phillips, PhD, Nello Blaser, MSc, Annick Borquez, PhD, Valentina Cambiano, MSc, Andrea Ciaranello, MD, Janne Estill, PhD, Richard Gray, PhD, Andrew Hill, PhD, Olivia Keiser, PhD, Jason Kessler, MD, Nicolas A Menzies, MPH, Kimberly A Nucifora, MS, Luisa Salazar Vizcaya, MSc, Simon Walker, MSc, Prof. Alex Welte, PhD, Philippa Easterbrook, MB, Meg Doherty, MD, Gottfried Hirnschall, MD, Prof. Timothy B Hallett, PhD
Publikováno v:
The Lancet Global Health, Vol 2, Iss 1, Pp e35-e43 (2014)
Background: WHO's 2013 revisions to its Consolidated Guidelines on antiretroviral drugs recommend routine viral load monitoring, rather than clinical or immunological monitoring, as the preferred monitoring approach on the basis of clinical evidence.
Externí odkaz:
https://doaj.org/article/98a0b829764949a28b7518c12eee5cb6